Taudia
1 known investors
Taudia develops SPLASH (Solid Phase Ligation Assay with Single wasH), an ultrasensitive protein biomarker quantification platform that runs on standard qPCR instruments to measure neurology biomarkers such as pTau-217, Aβ42, Aβ40, NfL, and GFAP from blood. Its singleplex, duplex, and 5-plex kits target Alzheimer's disease and neurology research labs for amyloid pathology assessment.
BiotechDigital HealthMedical Devices
Investors · 1
Frequently asked questions
- What does Taudia do?
- Taudia develops SPLASH (Solid Phase Ligation Assay with Single wasH), an ultrasensitive protein biomarker quantification platform that runs on standard qPCR instruments to measure neurology biomarkers such as pTau-217, Aβ42, Aβ40, NfL, and GFAP from blood. Its singleplex, duplex, and 5-plex kits target Alzheimer's disease and neurology research labs for amyloid pathology assessment.
- Who are Taudia's investors?
- Taudia's investors include Taiwan Global Angels.